An open-label, pilot study examining the efficacy of curettage followed by imiquimod 5% cream for the treatment of primary nodular basal cell carcinoma

Australasian Journal of Dermatology

Volumn 47, Issue 1, 2006, Pages 46-48

  Wu, Jason K ^a,b   Oh, Carol ^a   Strutton, Geoff ^a   Siller, Greg ^a  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b NONE   (Australia)

Author keywords

Curette; Non melanoma skin cancer

Indexed keywords

IMIQUIMOD;

ADULT; ARTICLE; BASAL CELL CARCINOMA; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COURSE EVALUATION; CYTOREDUCTIVE SURGERY; DISEASE COURSE; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PATIENT SATISFACTION; SHORT COURSE THERAPY; SKIN BIOPSY; SKIN DEFECT; SKIN NODULE; TISSUE SECTION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; AGED; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; BIOPSY, NEEDLE; CARCINOMA, BASAL CELL; COMBINED MODALITY THERAPY; CURETTAGE; EMOLLIENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PILOT PROJECTS; RISK ASSESSMENT; SINGLE-BLIND METHOD; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 33645011912     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2006.00222.x     Document Type: Article

References (16)

1. Geisse J Caro I Lindholm J Golitz L Stampone P Owens M. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies JAmAcadDermatol 2004 50 722 33
2. Geisse JK Rich P Pandya A Gross K Andres K Ginkel A Owens M. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study JAmAcadDermatol 2002 47 390 8
3. Marks R. Gebauer K Shumack S Amies M Bryden J Fox TL Owens ML. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial JAmAcadDermatol 2001 44 807 13
4. Shumack S Robinson J Kossard S Golitz L Greenway H Schroeter A Andres K Amies M Owens M. Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens ArchDermatol 2002 138 1165 71
5. Huber A Huber JD Skinner RB Kuwahara RT Haque R. Amonette RA. Topical imiquimod treatment for nodular basal cell carcinomas: an open-label series DermatolSurg 2004 30 429 30
6. Sterry W Ruzicka T Herrera E Takwale A Bichel J Andres K Ding L Thissen MR. Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion BrJDermatol 2002 147 1227 36
7. Silverman MK Kopf AW Grin CM Bart RS Levenstein MJ. Recurrence rates of treated basal cell carcinomas. Part 2: curettage-electrodesiccation JDermatolSurgOncol 1991 17 720 6
8. Kopf AW Bart RS Schrager D Lazar M Popkin GL. Curettage- electrodesiccation treatment of basal cell carcinomas ArchDermatol 1977 113 439 43
9. Spiller WF Spiller RF. Treatment of basal cell epithelioma by curettage and electrodesiccation JAmAcadDermatol 1984 11 808 14
10. Beutner KR Geisse JK Helman D Fox TL Ginkel A Owens ML. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream JAmAcadDermatol 1999 41 1002 7
11. Spencer JM Tannenbaum A Sloan L Amonette RA. Does inflammation contribute to the eradication of basal cell carcinoma following curettage and electrodesiccation? DermatolSurg 1997 23 625 30
12. Edens BL Bartlow GA Haghighi P Astarita RW Davidson TM. Effectiveness of curettage and electrodesiccation in the removal of basal cell carcinoma JAmAcadDermatol 1983 9 383 8
13. Suhge d'Aubermont PC Bennett RG. Failure of curettage and electrodesiccation for removal of basal cell carcinoma ArchDermatol 1984 120 1456 60
14. Goldman G. The current status of curettage and electrodesiccation DermatolClin 2002 20 569 78
15. Prado A Andrades P Benitez S Umana M. Scar management after breast surgery: preliminary results of a prospective, randomized, and double-blind clinical study with aldara cream 5% (imiquimod) PlastReconstrSurg 2005 115 966 72
16. Berman B Kaufman J. Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids JAmAcadDermatol 2002 47 S209 11